Clarity in cell line development

Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

  21st February 2019: Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s …

Read more Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

Solentim to Present and Exhibit at the ELRIG “CRISPR in Drug Discovery 2019” Conference in Oxford, UK

NEWS – Bournemouth, 11th February 2019: Solentim, a global leader in cell line development instrumentation, is pleased to announce they will be attending the ELRIG CRISPR in Drug Discovery 2019: From Targets to Therapeutics meeting on the 27-28 February, Oxford, UK. The meeting will focus on the application of genome engineering to identify novel drug targets through …

Read more Solentim to Present and Exhibit at the ELRIG “CRISPR in Drug Discovery 2019” Conference in Oxford, UK

Collaboration: changing CLD practices

In January 2019 Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, announced a technology partnering and collaboration agreement to enable rapid, high expression, stable cell line development. But what exactly are the tangible benefits gained from both parties and for customers, and why does this fusion of technology offer more …

Read more Collaboration: changing CLD practices

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This agreement creates the most efficient cell line development solution for biotherapeutic drug developers yet, by integrating Solentim’s VIPS™ (verified in-situ plate seeding) hardware for isolating single …

Read more Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Why is a clonally pure cell line so important in CRISPR research?

Never far from scientific and mainstream news, CRISPR is regularly hailed as one of the most important scientific discoveries of our time. With potential applications across wide-ranging fields from medicine to agriculture, being able to control gene expression could provide treatments for a number of genetic diseases and solve global food shortages in times of …

Read more Why is a clonally pure cell line so important in CRISPR research?